ArticleRheumatology advances in practice2019

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study.

John D Isaacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.